Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 1

1(25.0%)

Phase 4

1(25.0%)

4Total

N/A(2)

Phase 1(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT00777231Phase 1Completed

Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies

Role: collaborator

NCT02641158Not ApplicableCompleted

Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.

Role: collaborator

NCT01612169Not ApplicableCompleted

Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users

Role: collaborator

NCT01310582Phase 4Completed

Recovery Following Desflurane Versus Sevoflurane for Outpatient Urologic Surgery in Elderly Females

Role: lead

All 4 trials loaded